Skip to content

InEssence Studio

Active
Private limited companyfounded 2025less than a year activede Beaulieulaan 2 bte 38, 1160 Oudergem, BelgiumKBO/BCE: BE 1031.287.073
Summary

InEssence Studio is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €17,824 and a net result of €14,824. Its solvency ranks better than 73% of 22,158 sector peers (NACE 47, fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
InEssence StudioActiveChecked score 89/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€29,309total assets 2025
Equity
€17,824
Profit
€14,824
Turnover not published (micro schema)
Financial health
89 Excellent Checked score 2025
Too young for a probability
Structure
Accounts 32 days early
Why 89raises riskYoung companyneutralLatest accounts filed on timeShow the evidence

Checked score

Score 2025
89 / 100
Excellent
Without a bankruptcy probability: score from the figures alone
Every signal that weighs is under Signals.
Financial strength
Strong
Solvency 86
equity 60.8% of total assets
Liquidity 82
short-term debt 39.2% · cash 59.3%
Profitability 100
return on assets 50.6%
Bankruptcy probability, 12 months

This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.

Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 2.55; short-term debt: 39.2% and cash: 59.3% of total assets), and 39.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Two signals.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 0 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
32 days early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
Checked since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · micro…
  2. IncorporationAppointment: Sarah RUBENS (non-statutory director)…

Key points

  • Founded 10 months agofounded 08-12-2025 10 months View
  • One director decidessole director in office 1 View
  • Total assets 2025first fiscal year filed €29,309 View

By topic

Financials

Fiscal year
2025
Total assets
€29,309
Profit
€14,824
Solvency
60.8%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
08-12-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure